Overall Survival with Ribociclib plus Endocrine Therapy in Breast Cancer

Original Article

S.-A. Im, Y.-S. Lu, A. Bardia, N. Harbeck, M. Colleoni, F. Franke, L. Chow, J. Sohn, K.-S. Lee, S. Campos-Gomez, R. Villanueva-Vazquez, K.-H. Jung, A. Chakravartty, G. Hughes, I. Gounaris, K. Rodriguez-Lorenc, T. Taran, S. Hurvitz, and D. Tripathy

N Engl J Med 2019;381:307-316

Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation
Course opens: 
07/24/2019
Course expires: 
07/25/2021

Available Credit

  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Course closed

This course closed on Sunday, July 25, 2021 - 11:59pm.